Reforme

2002 · Best.-Nr. 63981 — Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 150 p. Includes illustrations. Serial No. 107-34. This hearing docussed on compassionate access to experimentatl drugs. Science dictated a gradual process of information gathering that often took 12 to 15 years from inception to product approval. Part of the process is to move to clinical trials for which formulations are labeled as investigational new drugs and preliminary safety data is obtained and a protocol designed before the clinical trials can move forward. The issue before the Congress was whether patients not part of the trial could otherwise be provided with the experimental drug what might save or extend their lives. U.S. Government Printing Office paperback